3/10/2008 Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
1/31/2008 Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
10/22/2007 Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
9/26/2007 Thermo Fisher Scientific and 21 Research Centers Welcome New Members To RNAi Global Initiative
6/19/2007 Thermo Fisher Scientific Launches RNAi Services Laboratory Supporting Researchers in Drug Discovery and Development
4/17/2007 Thermo Fisher Scientific RNA Technology Enables Groundbreaking Discovery in Cancer Research
11/10/2006 Merger of Thermo Electron and Fisher Scientific Completed, Forming Thermo Fisher Scientific
8/30/2006 Lentigen and Dharmacon Collaborate to Develop Custom Lentiviral Reagents for RNAi Research
7/13/2006 Harvard and Stanford Medical Schools and VUMC Join 12 International Research Centers and Dharmacon as Members of RNAi Global Initiative
7/6/2006 Abbott and Dharmacon Collaborate to Develop New siRNA-Based Therapeutics
6/6/2006 Dharmacon and Amaxa Collaborate to Improve siRNA Delivery into Cells
5/24/2006 RNAi Global Initiative Members Advance Standards for Genome-Wide RNAi Research in Second Meeting
4/4/2006 Fox Chase Cancer Center Joins Dharmacon and International Research Institutes as Newest Member of the Genome-Wide RNAi Global Initiative
1/5/2006 Alnylam Grants Dharmacon License to Kreutzer-Limmer Patents for the RNA Interference Research Products Market
12/29/2005 Dharmacon and MIT Settle RNAi License Dispute
12/7/2005 RNAi Global Initiative Members Meet to Establish Collaboration and Accelerate Biomedical Discovery Using Genome-Wide siRNA Library
10/19/2005 Dharmacon and Alcon to Collaborate on Discovery of New Therapies for Eye Diseases Using RNAi
10/6/2005 Dharmacon and 10 Leading Research Institutes Establish Global Initiative to Advance Research Using the World's First Human-Genome-Wide siRNA Library
7/27/2005 Dharmacon's Completion of First Human Genome-Wide siRNA Library Signals New Era in Life-Science Research
5/5/2005 Dharmacon to Deliver First Whole Human Genome-Wide siRNA Library
4/18/2005 Cancer Research UK Adopts Dharmacon Gene-Silencing Technology
4/15/2005 Dharmacon Launches siARRAY RTF siRNA Libraries - First-Ever Using Reverse Transfection Technology
1/21/2005 Dharmacon RNAi Technology Selected by Genetech to Support Drug Discovery Research
11/22/2004 Dharmacon and GE Healthcare Announce Exclusive RNAi Distribution Agreement for Japan -- RNAi Pioneer Joins With GE Healthcare To Market Gene Silencing Technology To Japanese Researchers
9/8/2004 Dharmacon Expands RNAi Supply Agreement with Wyeth
8/27/2004 Dharmacon Launches siGENOMETM siRNA for Mouse and Rat Genomes - Guaranteed Silencing for 24,000 Mouse Genes and 20,000 Rat Genes in RefSeq Database
7/22/2004 Dharmacon and Genospectra to Launch Genome-Wide Line of Novel RNA Assays for Gene Silencing Measurement - QuantiGene® Gene Expression Assays to be Paired with SMARTpool® Gene Silencing Reagents
6/15/2004 Dharmacon Expands siARRAYTM Line to Offer the Largest Available Collection of Human Gene Silencing Libraries Includes 18 siRNA Gene Family Libraries and siRNA Reagents Targeting 22,000 Unique Human Genes
5/6/2004 Dharmacon Named Best Reagent Company at RNAi-2004-Boston Meeting on RNA Interference: Biology to Drugs & Therapeutics
3/2/2004 Dharmacon and Bayer Pharmaceuticals Expand siRNA Supply Agreement --Dharmacon to Supply siRNA Reagents For 4,000 Gene Targets--
2/24/2004 Dharmacon Announces the Release of siGENOMETM siRNA Targeting the Entire Human Genome -- Gene Silencing Reagents For Over 22,000 Human Genes --
2/11/2004 Dharmacon Announces Agreement to be Acquired by Fisher Scientific -Acquisition Gives Dharmacon's Leading RNA Interference Technology Expanded Access to Global Research Markets -
2/2/2004 Dharmacon Publishes Rational siRNA Design Criteria and Supporting Validation Data In Nature Biotechnology --Eight Design Criteria To Be Included In Dharmacon's Free siRNA Design Tool--
1/8/2004 University of Massachusetts Medical School and Dharmacon Announce Diabetes and Obesity RNAi Collaboration
12/15/2003 Dharmacon Launches siSTABLETM siRNA with Greatly Increased Stability and Extended Silencing Longevity
11/24/2003 Dharmacon Launches siRNA Library With More Than 550 Protein Kinase Genes
11/10/2003 Dharmacon Enters into RNAi Supply Agreement with Bayer to Support Drug Discovery Research
11/3/2003 Dharmacon and Akceli Announce Research Collaboration to Combine Reverse Transfection and siRNA for High Throughput Gene Silencing
10/8/2003 Dharmacon and Merck's Rosetta Collaborate to Assess Multiple Factors Affecting Efficacy and Specificity of siRNA for Gene Silencing
9/15/2003 Odyssey Thera and Dharmacon Announce Collaboration to Elucidate Pathway Effects of siRNA-Induced Gene Silencing
8/14/2003 Dharmacon Launches ON-TARGETTM siRNA to Further Enhance the Specificity of siRNA-Mediated RNA Interference
8/5/2003 Dharmacon Awarded Patent for Key Chemical Component of 2'-ACE® Chemistry Technology
7/29/2003 Abbott Laboratories and Dharmacon Collaborate to Develop siRNA Library for Identification of New Drug Targets
6/24/2003 Agilent Technologies and Dharmacon to Use Microarrays to Analyze Cellular Effects of RNAi Gene Silencing for Drug Discovery Research
6/12/2003 Dharmacon and Exelixis to Develop 600 Gene siRNA Library
5/29/2003 Dharmacon Launches SARS siARRAYTM Gene Set Against SARS Virus -Makes Leading RNAi Tools Widely Available to Researchers to Study SARS and Potential Drug and Vaccine Leads
5/20/2003 Timothy Hoogheem Joins Dharmacon as Executive Vice President of Finance and Operations and CFO
5/6/2003 Michael Deines Joins Dharmacon as Vice President of Marketing
3/24/2003 Dharmacon Launches Cell Cycle Regulation Arrays, Expanding Its Genome-Wide siRNA Platform
2/26/2003 Dharmacon and Upstate Launch Combined siRNA and Antibody Kits for Enhanced Gene
12/5/2002 Dharmacon Enters Large-Scale Synthesis Market
10/24/2002 Dharmacon Nominated for the First Annual University of Colorado Technology Transfer Awards
10/23/2002 Dharmacon Research Appoints New Chief Operating Officer
9/10/2002 Dharmacon Research Appoints New Executive Vice President of R&D
8/23/2002 Dharmacon Research Receives $5.7 Million Equity Funding- Expansion of Synthetic RNA Production Capabilities Planned
8/23/2002 Dharmacon Research Forms Board of Directors
4/29/2002 MWG Biotech Partners with Dharmacon Research Inc. for High Quality RNA Synthesis